Login / Signup

Recombinant factor VIIa for hemorrhagic stroke treatment at earliest possible time (FASTEST): Protocol for a phase III, double-blind, randomized, placebo-controlled trial.

Andrew M NaidechJames GrottaJordan ElmScott JanisDariush DowlatshahiKazunori ToyodaThorsten SteinerStephan A MayerPooja KhanolkarJulie DenlingerHeinrich J AudebertCarlos MolinaPooja KhatriNikola SpriggAchala VagalJoseph P Broderick
Published in: International journal of stroke : official journal of the International Stroke Society (2021)
In the US, FASTEST will be first NIH StrokeNet Trial with an Exception from Informed Consent which allows enrollment of non-communicative patients without an immediately identifiable proxy.
Keyphrases